First-episode mania: A neglected priority for early intervention

Australian and New Zealand Journal of Psychiatry

Volumn 36, Issue 2, 2002, Pages 158-172

  Conus, Philippe ^a   McGorry, Patrick D ^a  

^a Early Psychosis Prev I   (Australia)

Author keywords

Early intervention; First episode; Mania; Outcome; Psychosis

Indexed keywords

BENZODIAZEPINE DERIVATIVE; LITHIUM; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; VALPROATE SEMISODIUM;

ARTICLE; CLINICAL RESEARCH; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DISEASE CLASSIFICATION; EXTRAPYRAMIDAL SYNDROME; FUNCTIONAL ASSESSMENT; HIGH RISK PATIENT; HUMAN; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL LITERATURE; MOOD; NEUROANATOMY; ONSET AGE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PREDICTION; PROGNOSIS; SCHIZOPHRENIA; SOCIAL CLASS; SUICIDE; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; BIPOLAR DISORDER; FEMALE; HUMANS; MALE; TIME FACTORS;

EID: 0036300575     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.2002.00994.x     Document Type: Article

References (104)

1. The recognition and management of early psychosis: A preventive approach
2. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National comorbidity survey
3. Symptoms and functioning of patients with bipolar disorder six months after hospitalisation
4. Outcome in manic disorders
5. Outcome in mania
6. The enduring psychosocial consequences of mania and depression
7. The effect of episodes on recurrence in affective disorder: A case register study
8. Cognitive impairment in the euthymic phase of affective disorder
9. Impaired neuropsychological performance in euthymic patients with recurring mood disorders
10. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence
11. Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder
12. Depression as a lethal disease: Prevention strategies
13. Four-year follow up of twenty-four first-episode manic patients
14. The McLean first-episode psychosis project. Six-month recovery and recurrence outcome
15. Mood-congruent versus mood-incongruent psychotic symptoms in first-admission patients with affective disorder
16. The longitudinal interval follow-up evaluation: A comprehensive method for assessíng outcome in prospective longitudinal studies
17. Effect of number of episodes on wellbeing and functioning of patients with bipolar disorder
18. Neuroleptics and the natural course of schizophrenia
19. Neurochemical sensitization in the pathophysiology of schizophrenia: Deficits and dysfunction in neuronal regulation and plasticity Neuropsychopharmacology
20. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
21. Outcome and comorbidity in first- compared with multiple-episode mania
22. The dimensional structure of first episode psychosis: An explanatory factor analysis
23. A comparison of the utility of dimensional and categorical representations of psychosis. UK700 group
24. A treatment relevant classification of psychotic disorders
25. One hundred years of schizophrenia: A meta-analysis of the outcome literature
26. Twelve-month outcome after first hospitalisation for affective psychosis
27. Eight-month functional outcome from mania following a first psychiatric hospitalisation
28. Levels of functioning and well-being in recovered psychotic versus nonpsychotic mania
29. The McLean-Harvard first-episode project. Six-month symptomatic and functional outcome in affective and nonaffective psychosis
30. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features
31. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania
32. A five-year prospective follow-up
33. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness
34. Twelve-month outcome of patients with bipolar disorder following hospitalisation for a manic or mixed episode
35. The McLean/Harvard first-episode mania project. Pharmacologic treatment and outcome
36. Outcome of patients with chronic affective disorder: A five-year follow-up
37. Phenomenology and outcome of subjects with early- and adult-onset psychotic mania
38. Phenomenology of adolescent and adult mania in hospitalized patients with bipolar disorder
39. Is early adulthood a critical developmental stage for psychosis proneness? A survey of delusional ideation in normal subjects
40. Comparison of patients with early-, typical-, and late-onset affective psychosis
41. Early and late onset bipolar disorders: Two different forms of manic-depressive illness?
42. Age of onset in bipolar affective disorder and misdiagnosis as schizophrenia
43. Establishing the onset of psychotic illness
44. Age of onset in affective disorder: Its correlation with hereditary and psychosocial factors
45. Mania, psychosis, and antipsychotics
46. Mood-congruent versus mood-incongruent psychotic symptoms in first-admission patients with affective disorder
47. Social outcome compared in psychotic and nonpsychotic bipolar I patients
48. Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders
49. Mood-congruent versus mood-incongruent psychotic symptoms in affective psychotic disorders
50. Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features
51. Is impaired outcome following a first manic episode due to mood-incongruent psychosis?
52. The predictive utility of schizophrenic symptoms in patients with a recent episode of mania
53. Twelve-month outcome of patients with DSM-III-R schizoaffective disorder: Comparisons to matched patients with bipolar disorder
54. Management of acute mania
55. Compliance with pharmacology in mood disorders
56. Factors associated with pharmacological noncompliance in patients with mania
57. Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders
58. The effect of antecedent substance abuse on the development of first-episode psychotic mania
59. Chronology of comorbid and principal syndromes in first-episode psychosis
60. Comorbidity in psychosis at first hospítalisation
61. Comorbidity in mania at first hospitalisation
62. Hierarchical diagnosis in chronic schizophrenia. A clinical study of co-occurring syndromes
63. Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalisation
64. Familial rates of affective and substance use disorder in patients with first-episode mania
65. The effect of comorbid alcoholism on recurrence in affective disorder: A case register study
66. Alcoholism in manic-depressive (bipolar) illness: Familial illness, course of illness, and the primary-secondary distinction
67. Neuropsychological performance of monozygotic twins discordant for bipolar disorder
68. Cognitive dysfunction in bipolar disorder: Evidence of neuropsychological disturbances
69. Information-processing anomalies in the early course of schizophrenia and bipolar disorder
70. Neuropsychological function in euthymic patients with bipolar disorder
71. Cognition, negative symptoms and diagnosis: A comparison of schizophrenic, bipolar, and control samples
72. Cognitive impairment and cerebral structure by MRI in bipolar disorder
73. Declarative and procedural memory in bipolar disorder
74. Cognitive deficits, psychopathology, and psychosocial functioning in bipolar mood disorder
75. Lithium induced cognitive side-effects in bipolar disorder: A qualitative analysis and implications for daily practice
76. Maintenance lithium treatment: Side effects and compliance
77. Attention and formal thought disorder in mixed and pure mania
78. Symptom correlates of attentional improvement following hospitalisation for a first episode of affective psychosis
79. A rating scale for mania: Reliability, validity and sensitivity
80. Neuropsychological differences between first-admission schizophrenia and psychotic affective disorders
81. Antipsychotic drug treatment in first-episode mania: A 6-month longitudinal study
82. Adjunctive treatment of manic agitation with lorazepam versus haloperidol: A double-blind study
83. Treatment of manic episodes in Scandinavia: The use of neuroleptic drugs in a clinical routine setting
84. Neuroleptic exposure following inpatients treatment of acute mania with lithium and neuroleptics
85. Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder
86. Survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients
87. Chronic neuroleptic use in manic-depressive illness
88. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia
89. Neuroimaging in bipolar disorder: What have we learned?
90. Structural brain abnormalities in first-episode mania
91. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder
92. MRI analysis of the cerebellum in bipolar disorder: A pilot study
93. Subgenual cingulate cortex volume in first-episode psychosis
94. Hippocampal volume in first-episode psychoses and chronic schizophrenia: A high-resolution magnetic resonance imaging study
95. Structural and functional brain changes in bipolar disorder: A selective review
96. Evaluating the importance of reducing the duration of untreated psychosis
97. Duration of untreated psychosis and 12-month outcome in first-episode psychosis: The impact of treatment approach
98. The prodromal phase of first-episode psychosis: Past and current conceptualizations
99. Is pre-psychotic intervention realistic in schizophrenia and related disorders?
100. Prediction of psychosis: A step towards indicated prevention of schizophrenia
101. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: Implications for the pathophysiology and treatment of manic-depressive illness